Chest
-
Pleural Disease/Pneumothorax PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Primary spontaneous pneumothorax (PSP) occurs in patients with no clinically apparent underlying lung disease. Those aged less than 50 year with no significant smoking history are also included in this group according to the British Thoracic Society (BTS) pneumothorax management algorithm. There is paucity of data on treatment outcomes based on age criteria. We aimed to compare treatment outcomes including successful re-inflation rates in patients aged <30 and 31-50. ⋯ The following authors have nothing to disclose: Muhammad Ganaie, Shiva Bikmalla, Masood Khalil, Muhammad Afridi, Mohammed Haris, Imran HussainNo Product/Research Disclosure Information.
-
Bronchology Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: As bronchial thermoplasty (BT) gains momentum across the nation for the treatment of severe refractory asthma, logistical questions arise regarding the manufacturer guidelines for use of FEV1 in determining patient eligibility and need for hospitalization post-procedure. Currently, the recommendations are to perform BT only in patients with pre-procedure FEV1 >65% and not discharge patients who have >20% drop in FEV1 post-procedure. We present a case of BT in which these guidelines were not adhered to, and yet the patient did extremely well without complications. ⋯ We present a case in which, by FEV1 values, the patient should have never had BT performed or been directly discharged home post-procedure. Yet this patient exceeded all expectations and did extremely well. Future studies are therefore needed to define the role of FEV1 measurements in bronchial thermoplasty.Reference #1: Castro et al. AJRCCM 2010;181(2):116-24Reference #2: Pavord et al. AJRCCM 2007;176(12):1185-91Reference #3: Cox et al. NEJM 2007;356(13):1327-37DISCLOSURE: The following authors have nothing to disclose: Ching-Fei Chang, Ian Lee, Courtney Kwan, Carla SalvadorNo Product/Research Disclosure Information.
-
COPD Epidemiology & Physiology PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: assessing the function of the right side of the heart .along with diagnosing of pulmonary hypertension and studying the hemodynamic abnormalities, thus Studying functional limitations of pulmonary hypertension on COPD patients. ⋯ The following authors have nothing to disclose: Medhat Soliman, Youssef Ameen, Usama AboelhassanNo Product/Research Disclosure Information.
-
Non-Invasive VentilationSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: Our objective is to investigate the outcome of HMV in ≥ 75 years to determine if there are differences respect to younger patients. ⋯ The following authors have nothing to disclose: María del Carmen García García, Jacinto Hernández Borge, Pedro Pires Goncalves, Estefanía Molina Ortiz, Pilar Cordero Montero, María Teresa Gómez Vizcaíno, Francisca Lourdes Márquez Pérez, José Antonio Marín Torrado, Ana Castañar Jover, Ignacio Rodríguez BlancoNo Product/Research Disclosure Information.
-
COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Limited data are available regarding the validation of the European respiratory society (ERS) guidelines recommendations in patients with acute exacerbations of COPD (AECOPD).The ERS use an A3 recommendation to consider Pseudomonas aeruginosa (PA) in the presence of at least two PA risk factors. Our aim was to validate the ERS PA risk factors recommendation among patients hospitalized with an AECOPD. ⋯ The following authors have nothing to disclose: Pedro Marcos, Pilar Sanjuan, Marina Blanco-Aparicio, Jorge Ricoy, Isabel Otero, Hector Verea, Marcos RestrepoNo Product/Research Disclosure Information.